Literature DB >> 21423265

Parkinson disease: Parkinson disease clinical subtypes and their implications.

Anthony H V Schapira, Anette Schrag.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21423265     DOI： 10.1038/nrneurol.2011.40

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

Review 1.  The heterogeneity of idiopathic Parkinson's disease.

Authors:  Thomas Foltynie; Carol Brayne; Roger A Barker
Journal:  J Neurol       Date:  2002-02       Impact factor: 4.849

Review 2.  The identification of Parkinson's disease subtypes using cluster analysis: a systematic review.

Authors:  Stephanie M van Rooden; Willem J Heiser; Joost N Kok; Dagmar Verbaan; Jacobus J van Hilten; Johan Marinus
Journal:  Mov Disord       Date:  2010-06-15       Impact factor: 10.338

Review 3.  Missing pieces in the Parkinson's disease puzzle.

Authors:  Jose A Obeso; Maria C Rodriguez-Oroz; Christopher G Goetz; Concepcion Marin; Jeffrey H Kordower; Manuel Rodriguez; Etienne C Hirsch; Matthew Farrer; Anthony H V Schapira; Glenda Halliday
Journal:  Nat Med       Date:  2010-05-23       Impact factor: 53.440

4.  A clinico-pathological study of subtypes in Parkinson's disease.

Authors:  M Selikhova; D R Williams; P A Kempster; J L Holton; T Revesz; A J Lees
Journal:  Brain       Date:  2009-09-16       Impact factor: 13.501

5.  Rationale for delayed-start study of pramipexole in Parkinson's disease: the PROUD study.

Authors:  Anthony H V Schapira; Stefan Albrecht; Paolo Barone; Cynthia L Comella; Michael P McDermott; Yoshikuni Mizuno; Werner Poewe; Olivier Rascol; Kenneth Marek
Journal:  Mov Disord       Date:  2010-08-15       Impact factor: 10.338

6.  Clinical subtypes of Parkinson's disease.

Authors:  Stephanie M van Rooden; Fabrice Colas; Pablo Martínez-Martín; Martine Visser; Dagmar Verbaan; Johan Marinus; Ray K Chaudhuri; Joost N Kok; Jacobus J van Hilten
Journal:  Mov Disord       Date:  2010-11-16       Impact factor: 10.338

Review 7.  The effect of onset age on the clinical features of Parkinson's disease.

Authors:  M M Wickremaratchi; Y Ben-Shlomo; H R Morris
Journal:  Eur J Neurol       Date:  2009-04       Impact factor: 6.089

8.  Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.

Authors:  Daniel G Healy; Mario Falchi; Sean S O'Sullivan; Vincenzo Bonifati; Alexandra Durr; Susan Bressman; Alexis Brice; Jan Aasly; Cyrus P Zabetian; Stefano Goldwurm; Joaquim J Ferreira; Eduardo Tolosa; Denise M Kay; Christine Klein; David R Williams; Connie Marras; Anthony E Lang; Zbigniew K Wszolek; Jose Berciano; Anthony H V Schapira; Timothy Lynch; Kailash P Bhatia; Thomas Gasser; Andrew J Lees; Nicholas W Wood
Journal:  Lancet Neurol       Date:  2008-06-06       Impact factor: 44.182

Review 9.  Molecular and clinical prodrome of Parkinson disease: implications for treatment.

Authors:  Anthony H V Schapira; Eduardo Tolosa
Journal:  Nat Rev Neurol       Date:  2010-05-18       Impact factor: 42.937

10.  Patterns of levodopa response in Parkinson's disease: a clinico-pathological study.

Authors:  P A Kempster; D R Williams; M Selikhova; J Holton; T Revesz; A J Lees
Journal:  Brain       Date:  2007-06-24       Impact factor: 13.501
  10 in total
  7 in total

Review 1.  Monoamine oxidase B inhibitors for the treatment of Parkinson's disease: a review of symptomatic and potential disease-modifying effects.

Authors:  Anthony H V Schapira
Journal:  CNS Drugs       Date:  2011-12-01       Impact factor: 5.749

Review 2.  Integrating Patient Concerns into Parkinson's Disease Management.

Authors:  Shen-Yang Lim; Ai Huey Tan; Susan H Fox; Andrew H Evans; Soon Chai Low
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

Review 3.  Early versus delayed initiation of pharmacotherapy in Parkinson's disease.

Authors:  Matthias Löhle; Carl-Johan Ramberg; Heinz Reichmann; Anthony H V Schapira
Journal:  Drugs       Date:  2014-04       Impact factor: 9.546

Review 4.  Clinical Aspects of the Differential Diagnosis of Parkinson's Disease and Parkinsonism.

Authors:  Hae-Won Shin; Sang-Wook Hong; Young Chul Youn
Journal:  J Clin Neurol       Date:  2022-05       Impact factor: 2.566

Review 5.  Recent developments in biomarkers in Parkinson disease.

Authors:  Anthony H V Schapira
Journal:  Curr Opin Neurol       Date:  2013-08       Impact factor: 5.710

6.  A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need.

Authors:  Kallol Ray Chaudhuri; Jose Manuel Rojo; Anthony H V Schapira; David J Brooks; Fabrizio Stocchi; Per Odin; Angelo Antonini; Richard G Brown; Richard J Brown; Pablo Martinez-Martin
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

7.  The Exosomal/Total α-Synuclein Ratio in Plasma Is Associated With Glucocerebrosidase Activity and Correlates With Measures of Disease Severity in PD Patients.

Authors:  Silvia Cerri; Cristina Ghezzi; Maria Sampieri; Francesca Siani; Micol Avenali; Gianluca Dornini; Roberta Zangaglia; Brigida Minafra; Fabio Blandini
Journal:  Front Cell Neurosci       Date:  2018-05-18       Impact factor: 5.505
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.